NuFund Venture Group — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Duo Oncologyduooncology.comin𝕏Feb 2021✓ verified
Duo Oncology is a clinical-stage company developing tumor-activated prodrug combinations intended to replace toxic multi-agent chemotherapy with single medicines that concentrate activity in tumors.
BiotechHealthtechPittsburgh, US
SONG LI(Director, Promoter)JING-ZHOU HOU(Executive Officer, Director, Promoter)Sam Rothstein(CEO & Cofounder)inKatherine Eichinger(Chief Operating Officer)STEPHEN THORNE(Executive Officer, Promoter)
BoardJOE GATTO(Director)in
Co-investorsUlu VenturesInnovation WorksNuFund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.